You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-Myeloma%20Activity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin Lymphoma, Multiple Myeloma Trial in China (Maplirpacept)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • Beijing, Beijing, China
  • +3 more
May 31, 2023

Multiple Myeloma Trial in Aichi, Okayama, Tokyo (Belantamab mafodotin, Bortezomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Aichi, Japan
  • +3 more
Feb 8, 2022

Anti-Xa Activity Trial in Vancouver (apixaban)

Terminated
Has Results
  • Anti-Xa Activity
  • Vancouver, British Columbia, Canada
    Vancouver General Hospital
Jul 28, 2021

Relapsed/Refractory Multiple Myeloma Trial in United States (UCARTCS1A)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • UCARTCS1A
  • San Francisco, California
  • +4 more
Nov 11, 2021

Relapsed or Refractory Multiple Myeloma Trial (Forimtamig, Carfilzomib, Daratumumab)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Sep 20, 2023

Myeloma Novel Drug Discovery Ver 1.2

Recruiting
  • Multiple Myeloma
  • Observational study - sample collection only.
  • London Borough of Sutton, United Kingdom
    The Royal Marsden NHS Foundation Trust
Aug 1, 2023

Multiple Myeloma Trial in Athens (Cevostamab, XmAb24306, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +1 more
Jan 2, 2023

Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Jul 13, 2023

Relapsed or Refractory Multiple Myeloma Trial (Cevostamab, Elranatamab, Tocilizumab)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Jun 22, 2023

Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in San Francisco (Manufactured Anti-BCMA CAR-T cells, Fludarabine,

Recruiting
  • Refractory Multiple Myeloma
  • Relapsed Multiple Myeloma
  • Manufactured Anti-BCMA CAR-T cells
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Anti-GPRC5D CAR-T Cells Injection)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Anti-GPRC5D CAR-T Cells Injection
  • (no location specified)
Feb 18, 2023

Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

Not yet recruiting
  • Multiple Myeloma
  • Allogeneic Stem Cell Transplantation
  • CARTemis-1
  • Santander, Cantabria, Spain
  • +4 more
Aug 1, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Actinium Ac 225-DOTA-Daratumumab, Daratumumab,

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Actinium Ac 225-DOTA-Daratumumab
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Multiple Myeloma Trial in Boston (Health Through Activity)

Not yet recruiting
  • Multiple Myeloma
  • Health Through Activity
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 17, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Kunming (Anti-GPRC5D CAR-T cells infusion)

Recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Anti-GPRC5D CAR-T cells infusion
  • Kunming, Yunnan, China
  • +1 more
Feb 21, 2023

Multiple Myeloma Trial in Canton (STI-6129)

Recruiting
  • Multiple Myeloma
  • STI-6129
  • Canton, Ohio
    Gabrail Cancer Center
Jun 29, 2022

Advanced Solid Tumor, Adult Disease, Multiple Myeloma Trial in Spain, Switzerland, United Kingdom (ANV419, CPI or

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Barcelona, Spain
  • +4 more
Dec 19, 2022

Vasopressors on Anti-Xa Activity in Critically Ill Patients

Recruiting
  • Critical Illness
  • Thrombosis
  • Serum anti-Xa activity
  • Gdańsk, Poland
    Medical University of Gdańsk - Departament of Anesthesiology and
Sep 20, 2023

Based on PRO Data Reported ThroughMHealth App Solution in

Completed
  • Multiple Myeloma
  • mHealth app
  • Odense, Denmark
    Odense University Hospital
Feb 10, 2023

Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 11, 2022

Multiple Myeloma Trial in Xuzhou (anti-BCMA/GPRC5D CAR-T CELL)

Recruiting
  • Multiple Myeloma
  • anti-BCMA/GPRC5D CAR-T CELL
  • Xuzhou, Jiangsu, China
    Kailin Xu
Aug 19, 2022

Relapsed Refractory Multiple Myeloma Trial (REGN5458, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Relapsed Refractory Multiple Myeloma
  • (no location specified)
Feb 6, 2023

Multiple Myeloma, Adapted Physical Activity, Chronic Pain Trial (adapted physical activity)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • adapted physical activity
  • (no location specified)
Sep 19, 2022

Multiple Myeloma Trial (Bela, Belamaf, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jan 27, 2023

Multiple Myeloma Trial in Rochester (behavioral, other, procedure)

Not yet recruiting
  • Multiple Myeloma
  • Supportive Care (home-based physical activity)
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023